ESCRS 2023: Device-centric focus drives a redesign at Geuder

News
Video

Two members of the team gave a preview of Geuder’s 2024 spotlight products

The latest and greatest devices in ophthalmology were on full display at the European Society of Cataract and Refractive Surgeons (ESCRS) meeting. The Messe Wien exhibition centre in Vienna, Austria, was filled with eye care experts, some showing off their recent developments, others getting to know the next generation of tools and tech.

At the Geuder booth, we spoke with Tomislav Bucalic, head of marketing, and David Geuder, CIO and executive board member. They told us a recent rebranding continues the company’s mission at ESCRS: putting their showcase devices and instruments first. Watch the video to learn about some of the recent developments that will receive a special spotlight on the new Geuder website.

Editor’s note: This transcript has been lightly edited for clarity.

Tomislav Bucalic: Hello, I'm Tomislav Bucalic. I'm the head of marketing at Geuder.

David Geuder: My name is David Geuder. I'm a member of the board since the beginning of this year. We are celebrating this year our newest device, our [Vivos] phaco machine.

Tomislav Bucalic: Which is a great achievement after 10 or 12 years with the old machine. It's a brand new device with [inaudible] USPs [ultrasonic phaco], an active pump system, which makes sure that you have little anterior chamber depth variation. You have very high vacuum levels, high irrigation and the perfect balance between irrigation and aspiration.

We have a lot of changes. We did a corporate rebranding.

David Geuder: Many, many customers and many people, I imagine...are seeing our new, our new design–our new corporate redesign, and of course, our focus products.

Tomislav Bucalic: We'll be more focused on the products we love. To show, say, our forceps–I think there is only a few, probably only one company in the world, who can produce a 27-gauge cannula with an integrated forceps.

David Geuder: Scroll over the website. They will be surprised with our new design.

Tomislav Bucalic: People know that we offer a wide range of instruments and devices. But there are some specific products which we really love, and which show our passion for ophthalmology.



Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.